DENVER, Colo., Sept 27, 2023 (www.247marketnews.com)- The following stocks are the top performing U.S. stocks over the past week; Vaccitech (NASDAQ: VACC), Siyata Mobile (NASDAQ: SYTA), Soleno Therapeutics (NASDAQ: SLNO), Femasys (NASDAQ: FEMY), Immunovant (NASDAQ: IMVT), and Intercept Pharma (NASDAQ: ICPT)
Vaccitech and Siyata Mobile made yesterday’s list, while the other four were added after massive news driven moves.
Vaccitech (NASDAQ:VACC) opened trading last Wednesday at $1.68 and traded very lightly until Monday, when it opened at $1.64, a new 52-week low, but then, like someone flipped the switch, it took off to hit a high of $4.35, a new 52-week high. It may be rolling over as it closed yesterday at $2.82, down $0.34 (-10.76%), on 2.12M shares traded, but it’s still 59.43% higher for the 5-day period.
Its most recent announcement was “Vaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023” September 13, 2023.
We hoped that it would consolidate at $3, or better, but, so far, it’s not cooperating.
Siyata Mobile (NASDAQ: SYTA) opened trading last Wednesday at $2.05, after bouncing off its 52-week lows. It closed at $2.94, up $0.34 (+13.08%), on 115.4K shares traded. It’s 43.41% higher for the 5-day period.
Its most recent announcement was “Siyata Mobile Announces Follow-On Order from Large North American Waste Management Provider” September 18, 2023
It’s broken the downward trend on the one-month chart and is getting close to doing the same on the six-month chart. It still looks like it wants to challenge the $3.50 level.
Soleno Therapeutics (NASDAQ:SLNO) opened trading last Wednesday at $4.51 and traded very lightly until yesterday, when it opened at $21.00 and hit a new 52-week high of $30.30. It closed at $26.80, up $22.37 (+504.97%), on 41.8M shares traded. It’s 494.24% higher for the 5-day period.
Its most recent announcement was “Soleno Therapeutics Announces Positive Statistically Significant Top-line Results from Randomized Withdrawal Period of Study C602 of DCCR for Prader-Willi Syndrome” September 26, 2023
Unless a bunch of shorters are still stuck in this, it’s hard to picture this running much higher until it’s had some time to consolidate in the twenties.
Femasys (NASDAQ: FEMY) opened trading last Wednesday at $0.33 and traded sideways until yesterday, when it opened at $1.22, hit a high of $1.66, before closing at $1.48, up $1.1484 (+346.32%), on 191.9M shares traded. It’s 359.66% higher for the 5-day period.
Its most recent announcement was “Femasys Inc. Receives U.S. FDA Clearance to Market FemaSeed, an Innovative Infertility Treatment Solution” September 25, 2023
Immunovant (NASDAQ: IMVT) opened trading last Wednesday at $21.48 and traded sideways until yesterday, when it took off and hit a high of $41.7199 and closed at $39.96, up $19.68 (+97.04%), on 35.1M shares traded. It’s 86.03% higher for the 5-day period.
Its most recent announcements were “Immunovant Announces Positive Initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results” and “Immunovant Announces Proposed Offering of $300 Million of Common Stock” September 26, 2023
It’s now testing its 2020 trading levels.
Intercept Pharma (NASDAQ: ICPT) opened trading last Wednesday at $11.09 and traded sideway, until it took off yesterday and closed at $18.71, up $8.27 (+79.21%), on 37.3M shares traded. It’s 68.94% higher for the 5-day period.
Its most recent announcement was “Alfasigma to Acquire Intercept Pharmaceuticals for $19.00 per Share in Cash, Expanding the Global Footprint of Alfasigma Via a Leader in Rare and Serious Liver Diseases” September 26, 2023
Its price is probably not going to move much from here.
Link to disclosure here.
